GlyTR Therapeutics Announces Publication of Pan-Cancer Immunotherapy Platform Study in Cell

GlyTR Therapeutics announced the publication of a study in Cell detailing their Glycan-Dependent T cell Recruiter (GlyTR1 & GlyTR2) therapeutics. Thes...
Home/KnloSights/Clinical Trial Updates/GlyTR Therapeutics Announces Publication of Pan-Cancer Immunotherapy Platform Study in Cell